Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis.

Barchiesi F, Spreghini E, Sanguinetti M, Giannini D, Manso E, Castelli P, Girmenia C.

J Antimicrob Chemother. 2013 Nov;68(11):2587-91. doi: 10.1093/jac/dkt232. Epub 2013 Jun 21.

PMID:
23794598
2.

In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.

Spreghini E, Orlando F, Tavanti A, Senesi S, Giannini D, Manso E, Barchiesi F.

J Antimicrob Chemother. 2012 Sep;67(9):2195-202. doi: 10.1093/jac/dks180. Epub 2012 May 25.

PMID:
22635526
3.

Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

Spreghini E, Orlando F, Sanguinetti M, Posteraro B, Giannini D, Manso E, Barchiesi F.

Antimicrob Agents Chemother. 2012 Mar;56(3):1215-22. doi: 10.1128/AAC.05872-11. Epub 2011 Dec 27.

4.

Heterozygosis and pathogenicity of Cryptococcus neoformans AD-hybrid isolates.

Cogliati M, Barchiesi F, Spreghini E, Tortorano AM.

Mycopathologia. 2012 Jun;173(5-6):347-57. doi: 10.1007/s11046-011-9467-x. Epub 2011 Sep 16.

PMID:
21922248
5.

In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.

Spreghini E, Orlando F, Giannini D, Barchiesi F.

J Antimicrob Chemother. 2010 Oct;65(10):2158-63. doi: 10.1093/jac/dkq276. Epub 2010 Jul 28.

PMID:
20667887
6.

Disruption of homocitrate synthase genes in Candida albicans affects growth but not virulence.

Kur K, Gabriel I, Morschhäuser J, Barchiesi F, Spreghini E, Milewski S.

Mycopathologia. 2010 Dec;170(6):397-402. doi: 10.1007/s11046-010-9337-y. Epub 2010 Jun 23.

PMID:
20571912
7.

Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.

Spreghini E, Orlando F, Santinelli A, Pisa E, Loretelli C, Manso E, Milici ME, Scalise G, Barchiesi F.

Antimicrob Agents Chemother. 2009 Sep;53(9):4035-9. doi: 10.1128/AAC.00659-09. Epub 2009 Jul 13.

8.

In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.

Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A, Scalise G.

Med Mycol. 2009 May;47(3):321-6. doi: 10.1080/13693780802641920. Epub 2008 Dec 27.

PMID:
19115137
9.

Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.

Maida CM, Milici ME, Trovato L, Oliveri S, Amodio E, Spreghini E, Scalise G, Barchiesi F.

J Clin Microbiol. 2008 Dec;46(12):4071-4. doi: 10.1128/JCM.01088-08. Epub 2008 Oct 15.

10.

Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.

Spreghini E, Maida CM, Tomassetti S, Orlando F, Giannini D, Milici ME, Scalise G, Barchiesi F.

Antimicrob Agents Chemother. 2008 Jun;52(6):1929-33. doi: 10.1128/AAC.00130-08. Epub 2008 Apr 7.

11.

Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.

Spreghini E, Maida CM, Milici ME, Scalise G, Barchiesi F.

Antimicrob Agents Chemother. 2008 Feb;52(2):513-7. Epub 2007 Dec 3.

12.

Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.

Milici ME, Maida CM, Spreghini E, Ravazzolo B, Oliveri S, Scalise G, Barchiesi F.

J Clin Microbiol. 2007 Nov;45(11):3529-33. Epub 2007 Aug 29.

13.

Fluconazole susceptibility of Candida spp. isolates collected over nine years in a teaching hospital of Ancona, Italy.

Barchiesi F, Arzeni D, Greganti G, Marigliano A, Tomassetti S, Spreghini E, Scalise G.

J Chemother. 2007 Feb;19(1):58-61.

PMID:
17309852
14.

Caspofungin in combination with amphotericin B against Candida parapsilosis.

Barchiesi F, Spreghini E, Tomassetti S, Giannini D, Scalise G.

Antimicrob Agents Chemother. 2007 Mar;51(3):941-5. Epub 2006 Dec 11.

15.

Posaconazole prophylaxis in experimental systemic zygomycosis.

Barchiesi F, Spreghini E, Santinelli A, Fothergill AW, Pisa E, Giannini D, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2007 Jan;51(1):73-7. Epub 2006 Oct 23.

16.

Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.

Barchiesi F, Spreghini E, Tomassetti S, Della Vittoria A, Arzeni D, Manso E, Scalise G.

Antimicrob Agents Chemother. 2006 Aug;50(8):2719-27.

17.

Candida guilliermondii fungemia in patients with hematologic malignancies.

Girmenia C, Pizzarelli G, Cristini F, Barchiesi F, Spreghini E, Scalise G, Martino P.

J Clin Microbiol. 2006 Jul;44(7):2458-64.

18.

Efficacy of caspofungin against Aspergillus terreus.

Barchiesi F, Spreghini E, Santinelli A, Fothergill AW, Fallani S, Manso E, Pisa E, Giannini D, Novelli A, Cassetta MI, Mazzei T, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2005 Dec;49(12):5133-5.

19.

Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.

Barchiesi F, Spreghini E, Tomassetti S, Arzeni D, Giannini D, Scalise G.

Antimicrob Agents Chemother. 2005 Dec;49(12):4989-92.

20.

Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.

Barchiesi F, Cogliati M, Esposto MC, Spreghini E, Schimizzi AM, Wickes BL, Scalise G, Viviani MA.

J Infect. 2005 Jul;51(1):10-6.

PMID:
15979484
21.

Caspofungin in combination with amphotericin B against Candida glabrata.

Barchiesi F, Spreghini E, Fothergill AW, Arzeni D, Greganti G, Giannini D, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2005 Jun;49(6):2546-9.

22.

Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates.

Barchiesi F, Tortorano AM, Di Francesco LF, Rigoni A, Giacometti A, Spreghini E, Scalise G, Viviani MA.

J Med Microbiol. 2005 Mar;54(Pt 3):279-85.

PMID:
15713612
23.

Tolerance to amphotericin B in clinical isolates of Candida tropicalis.

Barchiesi F, Maracci M, Baldassarri I, Spreghini E, Giannini D, Scalise G.

Diagn Microbiol Infect Dis. 2004 Nov;50(3):179-85.

PMID:
15541603
24.

Sequential therapy with caspofungin and fluconazole for Candida albicans infection.

Barchiesi F, Spreghini E, Baldassarri I, Marigliano A, Arzeni D, Giannini D, Scalise G.

Antimicrob Agents Chemother. 2004 Oct;48(10):4056-8.

25.

In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.

Barchiesi F, Spreghini E, Maracci M, Fothergill AW, Baldassarri I, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2004 Sep;48(9):3317-22.

26.

Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.

Barchiesi F, Spreghini E, Schimizzi AM, Maracci M, Giannini D, Carle F, Scalise G.

Antimicrob Agents Chemother. 2004 Sep;48(9):3312-6.

27.

Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation.

Spreghini E, Davis DA, Subaran R, Kim M, Mitchell AP.

Eukaryot Cell. 2003 Aug;2(4):746-55.

28.
29.
30.

Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.

de Bernardis F, Santoni G, Boccanera M, Spreghini E, Adriani D, Morelli L, Cassone A.

Infect Immun. 2000 Jun;68(6):3297-304.

31.

Impairment of rat thymocyte differentiation and functions by neonatal capsaicin treatment is associated with induction of apoptosis.

Santoni G, Perfumi MC, Pompei P, Spreghini E, Lucciarini R, Martarelli D, Staffolani M, Piccoli M.

J Neuroimmunol. 2000 Apr 3;104(1):37-46.

PMID:
10683513
32.

Alterations of T cell distribution and functions in prenatally cypermethrin-exposed rats: possible involvement of catecholamines.

Santoni G, Cantalamessa F, Spreghini E, Sagretti O, Staffolani M, Piccoli M.

Toxicology. 1999 Nov 15;138(3):175-87.

PMID:
10593508
33.

Neurokinin type-1 receptor antagonist inhibits enhancement of T cell functions by substance P in normal and neuromanipulated capsaicin-treated rats.

Santoni G, Perfumi MC, Spreghini E, Romagnoli S, Piccoli M.

J Neuroimmunol. 1999 Jan 1;93(1-2):15-25.

PMID:
10378865
34.
35.

Cypermethrin-induced alteration of thymocyte distribution and functions in prenatally-exposed rats.

Santoni G, Cantalamessa F, Cavagna R, Romagnoli S, Spreghini E, Piccoli M.

Toxicology. 1998 Jan 16;125(1):67-78.

PMID:
9585102
36.

Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.

De Bernardis F, Boccanera M, Adriani D, Spreghini E, Santoni G, Cassone A.

Infect Immun. 1997 Aug;65(8):3399-405.

Supplemental Content

Loading ...
Support Center